Literature DB >> 16340096

Parkinson's Disease Research Education and Clinical Centers (PADRECC): background and overview.

Natalie Diaz1, Jeff M Bronstein.   

Abstract

Parkinson's disease (PD) afflicts more than 1,000,000 people in the United States and over 50,000 veterans obtain their medical care for PD within the Veterans Health Care System. In an effort to improve care for this growing population of veterans suffering from PD, the Veteran's Health Administration established 6 Parkinson's disease Research, Education, and Clinical Centers (PADRECC) based on merit. These 6 centers offer state of the art diagnosis and treatment of PD and other movement disorders. The PADRECC also provide education for both the professional community and patients not only at the 6 sites, but also throughout the VA system through the development of a national consortium. Improving veterans' health care through research is also a priority for the PADRECC. All 6 PADRECC are participating in the largest surgical trial for the treatment of PD ever performed. Heath service researchers have already identified quality of care indicators that are now being used to evaluate care for veterans with PD. Basic researchers at the PADRECC are studying the cause of PD and are developing new therapies including stem cells. The development of the PADRECC has created an important infrastructure and attracted expertise into the VA system. They have already made great improvements in caring for veterans with PD and promises to push the field further with their research efforts.

Entities:  

Mesh:

Year:  2005        PMID: 16340096

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  3 in total

1.  Cardiovascular Risk Factor Burden in Veterans and Non-Veterans with Parkinson Disease.

Authors:  Vikas Kotagal; Roger L Albin; Martijn L T M Müller; Nicolaas I Bohnen
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

2.  Understanding health care needs among Veterans with Parkinson's disease: A survey study.

Authors:  Megan Feeney; John Duda; Amie Hiller; Jay Phillips; Christiana Evers; Nicole Yarab; Veronica Todaro; Lydia Rader; Sheera Rosenfeld
Journal:  Front Neurol       Date:  2022-08-11       Impact factor: 4.086

3.  Seizure control in patients with epilepsy: the physician vs. medication factors.

Authors:  Jerzy P Szaflarski; Angela Y Rackley; Christopher J Lindsell; Magdalena Szaflarski; Stephen L Yates
Journal:  BMC Health Serv Res       Date:  2008-12-18       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.